Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence:Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2
Molecular Weight:
1416.06
Purity:
>96%
CAS Number:
[183552-38-7]
Formula:
C72H95ClN14O14
Target:
LHRH/GnRH
* VAT and and shipping costs not included. Errors and price changes excepted